基于蒙特卡罗方法的BNCT头部肿瘤案例的剂量学研究

BNCT dosimetric study of head tumor cases based on Monte-Carlo methods

  • 摘要: 硼中子俘获治疗(BNCT)作为创新型二元靶向治疗技术,利用靶向10B药物与中子束协同,实现细胞级精准治疗。但受限于复杂的中子输运过程,蒙特卡罗治疗计划计算极其耗时,且针对头部肿瘤的剂量学研究存在空白。针对BNCT治疗需求,基于NECP-MCX开展了蒙特卡罗算法的加速优化与前后处理模块开发,将单次剂量计算时间从2 h缩短至9.4 min;并采用MCNP与NECP-MCX两种蒙特卡罗程序,对一例头部肿瘤病例开展剂量分布计算研究,验证了前后端处理和计算核心的准确性,也确保了数据可靠。该肿瘤案例的计算结果表明,在有效治疗深度内,具有显著的肿瘤靶向硼剂量沉积特性。在治疗效果方面,BNCT单次治疗需63分钟完成,在确保肿瘤靶区90%体积达到60 Gy最佳处方剂量的同时,可将健康组织受量控制在12.5 Gy以下。

     

    Abstract:
    Background Boron neutron capture therapy (BNCT) is an innovative binary targeted cancer treatment technology with high relative biological effect and cell-scale precision; however, its clinical application is limited by the long computation time of traditional Monte-Carlo methods for dose calculation and the lack of sufficient dosimetric research on head tumors.
    Purpose This study aims to address these challenges by optimizing the Monte-Carlo algorithm and developing pre-processing/post-processing modules, verifying the accuracy of the computational system, and analyzing the dosimetric characteristics of BNCT for head tumors.
    Methods Based on NECP-MCX, three acceleration strategies, voxel geometry fast tracking, transport-counting integration, and MPI parallel optimization, were adopted to improve computational efficiency. Pre-processing (DICOM image parsing, material-boron concentration mapping, 3D voxel modeling) and post-processing (dose-depth curve, Dose-Volume Histogram (DVH), dose distribution map) modules were developed. Both NECP-MCX and MCNP were used to calculate the dose distribution of a head tumor case (RADCURE-700) for comparison.
    Results The single-dose calculation time was reduced from 2 h to 9.4 min. The dose curves, DVH, and dose distribution maps from the two programs showed good consistency with relative deviations below 5% within a depth of 10 cm. The resulting BNCT treatment plan achieved a tumor target volume D90 of 60 Gy in 63 min , with healthy tissue dose below 12.5 Gy.
    Conclusions The optimized NECP-MCX system realizes efficient and accurate dose calculation for BNCT. The consistent results validate its reliability, and the dosimetric analysis demonstrates the potential of BNCT for head tumor treatment, providing methodological support for clinical treatment planning.

     

/

返回文章
返回